Pub Date : 2026-03-20DOI: 10.1016/j.cstres.2026.100175
Lei Zhang, Pu Zhang, Mingna Tang, Ruifeng Shi
Bone marrow contains abundant free fatty acids (FFA). Abnormal accumulation of FFAs can be triggered by pathological or physiologic conditions such as hyperlipidemia, diabetes mellitus, and menopause, leading to osteoporosis. Excess FFAs impair bone homeostasis by promoting osteoclast-mediated bone resorption and inhibiting the proliferation and differentiation of osteoblasts. C-type lectin domain family 11 member A (Clec11a) is an osteogenic growth factor that can protect islet proliferation and function against lipotoxicity. However, there is a lack of research on the function of Clec11a under bone marrow lipotoxic conditions. Here, we demonstrate that Clec11a counteracts the lipotoxicity-induced osteogenic inhibition and facilitates the proliferation and differentiation of osteoblasts. Clec11a effectively reverses palmitic acid(PA)-induced suppression of osteoblast proliferation and osteogenic differentiation, alleviates oxidative stress, and maintains mitochondrial homeostasis. Mechanistically, these protective effects of Clec11a depend on the SIRT3-SOD2 signaling axis, as the SIRT3 inhibitor 3-TYP abolishes its effects in both MC3T3-E1 cells and mouse bone marrow mesenchymal stem cells. Collectively, our findings reveal that Clec11a protects osteoblasts from PA-induced damage through regulation of the SIRT3-SOD2 signaling axis, providing mechanistic insights into bone impairment under lipotoxic conditions.
{"title":"Clec11a Protects Osteogenic Differentiation of MC3T3-E1 Cells Against Lipotoxicity by Inhibiting Oxidative Stress.","authors":"Lei Zhang, Pu Zhang, Mingna Tang, Ruifeng Shi","doi":"10.1016/j.cstres.2026.100175","DOIUrl":"https://doi.org/10.1016/j.cstres.2026.100175","url":null,"abstract":"<p><p>Bone marrow contains abundant free fatty acids (FFA). Abnormal accumulation of FFAs can be triggered by pathological or physiologic conditions such as hyperlipidemia, diabetes mellitus, and menopause, leading to osteoporosis. Excess FFAs impair bone homeostasis by promoting osteoclast-mediated bone resorption and inhibiting the proliferation and differentiation of osteoblasts. C-type lectin domain family 11 member A (Clec11a) is an osteogenic growth factor that can protect islet proliferation and function against lipotoxicity. However, there is a lack of research on the function of Clec11a under bone marrow lipotoxic conditions. Here, we demonstrate that Clec11a counteracts the lipotoxicity-induced osteogenic inhibition and facilitates the proliferation and differentiation of osteoblasts. Clec11a effectively reverses palmitic acid(PA)-induced suppression of osteoblast proliferation and osteogenic differentiation, alleviates oxidative stress, and maintains mitochondrial homeostasis. Mechanistically, these protective effects of Clec11a depend on the SIRT3-SOD2 signaling axis, as the SIRT3 inhibitor 3-TYP abolishes its effects in both MC3T3-E1 cells and mouse bone marrow mesenchymal stem cells. Collectively, our findings reveal that Clec11a protects osteoblasts from PA-induced damage through regulation of the SIRT3-SOD2 signaling axis, providing mechanistic insights into bone impairment under lipotoxic conditions.</p>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":" ","pages":"100175"},"PeriodicalIF":3.2,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147497803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-20DOI: 10.1016/j.cstres.2026.100174
Yang Yue, Hai Feng Chen, Lei Liu
As the largest human organ, the skin experiences lifelong exposure to intrinsic/extrinsic factors that over time diminish its functional capacity and structural integrity. Skin aging involves cellular dysfunction and the loss or fragmentation of extracellular matrix (ECM) fibers, clinically presenting as wrinkles, slackening, and pigmentary abnormalities. The heat shock response (HSR) is a gene regulatory program that controls the expression of molecular chaperones associated with aging, cancer, and neurodegenerative disorders. By maintaining cellular homeostasis and facilitating DNA repair, HSR exerts protective effects against skin aging, as utilized in aesthetic technologies such as radiofrequency and focused ultrasound. This study aimed to investigate the mechanism, optimal conditions, and potential risks of short-term heat shock (HS) on the senescence process of human foreskin fibroblasts (HFF-1), providing experimental evidence to support the application of thermal stress in delaying skin aging. A replicative senescence model of HFF-1 cells was first established. Subsequently, cells were subjected to HS at 41 °C, 45 °C, and 49 °C, with a control group maintained at 37 °C. Assessments, including cell proliferation and viability assays, apoptosis analysis, reactive oxygen species (ROS) levels, Western blot, and heat shock proteins (HSPs) mRNA expression, demonstrated that 49 °C HS induced irreversible cellular damage. In contrast, 30min HS at 41 °C and 45 °C attenuated senescence-associated phenotypes to varying extents under our experimental conditions.
{"title":"Proteomic and Phenotypic Profiling of Replicative-Senescent HFF-1 Fibroblasts Under Brief Heat Shock.","authors":"Yang Yue, Hai Feng Chen, Lei Liu","doi":"10.1016/j.cstres.2026.100174","DOIUrl":"https://doi.org/10.1016/j.cstres.2026.100174","url":null,"abstract":"<p><p>As the largest human organ, the skin experiences lifelong exposure to intrinsic/extrinsic factors that over time diminish its functional capacity and structural integrity. Skin aging involves cellular dysfunction and the loss or fragmentation of extracellular matrix (ECM) fibers, clinically presenting as wrinkles, slackening, and pigmentary abnormalities. The heat shock response (HSR) is a gene regulatory program that controls the expression of molecular chaperones associated with aging, cancer, and neurodegenerative disorders. By maintaining cellular homeostasis and facilitating DNA repair, HSR exerts protective effects against skin aging, as utilized in aesthetic technologies such as radiofrequency and focused ultrasound. This study aimed to investigate the mechanism, optimal conditions, and potential risks of short-term heat shock (HS) on the senescence process of human foreskin fibroblasts (HFF-1), providing experimental evidence to support the application of thermal stress in delaying skin aging. A replicative senescence model of HFF-1 cells was first established. Subsequently, cells were subjected to HS at 41 °C, 45 °C, and 49 °C, with a control group maintained at 37 °C. Assessments, including cell proliferation and viability assays, apoptosis analysis, reactive oxygen species (ROS) levels, Western blot, and heat shock proteins (HSPs) mRNA expression, demonstrated that 49 °C HS induced irreversible cellular damage. In contrast, 30min HS at 41 °C and 45 °C attenuated senescence-associated phenotypes to varying extents under our experimental conditions.</p>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":" ","pages":"100174"},"PeriodicalIF":3.2,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147497785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-13DOI: 10.1016/j.cstres.2026.100166
Mariah Stewart, Chathura Paththamperuma, Colleen McCann, Kelsey Cottingim, Huaqun Zhang, Rian DelVecchio, Ivy Peng, Erica Fennimore, Jay C Nix, Morcos N Saeed, Kathleen George, Katherine Makaroff, Meagan Colie, Ethan Paulakonis, Michael F Almeida, Adeleye J Afolayan, Nicholas G Brown, Richard C Page, Jonathan C Schisler
Heat shock protein 70 (HSP70) and its E3 ligase co-chaperone CHIP (STUB1) form a critical quality-control complex that directs client proteins toward folding or degradation. Phosphorylation of HSP70 at a conserved threonine in the C-terminal tail influences the fate of clients during cellular stress, yet the structural basis for this regulation remains unclear. Here, we present crystal structures of the CHIP tetratricopeptide repeat (TPR) domain bound to unphosphorylated and phosphorylated HSP70 C-terminal peptides at 1.6-1.9Å resolution. Phosphate occupancy at Thr636 (HSPA1A numbering) causes steric clashes and electrostatic repulsion within the TPR-binding groove, decreasing affinity by more than 10-fold, as shown by biolayer interferometry and fluorescence polarization. Molecular dynamics simulations confirm destabilization of key hydrogen bonds. A structure-guided G132N substitution in CHIP introduces new hydrogen bonds to the phosphate group, restoring affinity for phosphorylated peptides in isolated TPR domains without losing native ubiquitination activity. However, in full-length CHIP, interface modifications do not restore phosphorylation-impaired stable binding but yield only partial recovery of transient interactions in cells, indicating additional context-dependent constraints on HSP70-CHIP regulation. These findings reveal the atomic mechanism by which phosphorylation impairs HSP70-CHIP interaction during stress and demonstrate that targeted interface engineering can compensate for post-translational changes in isolated domains. Overall, the results explain how cells switch chaperone-mediated triage pathways and offer a framework for understanding how proteostasis becomes dysregulated in neurodegenerative diseases and cancer.
{"title":"Crystal structures reveal phosphorylation-dependent disruption of the HSP70-CHIP interface; a compensatory G132N variant restores binding affinity.","authors":"Mariah Stewart, Chathura Paththamperuma, Colleen McCann, Kelsey Cottingim, Huaqun Zhang, Rian DelVecchio, Ivy Peng, Erica Fennimore, Jay C Nix, Morcos N Saeed, Kathleen George, Katherine Makaroff, Meagan Colie, Ethan Paulakonis, Michael F Almeida, Adeleye J Afolayan, Nicholas G Brown, Richard C Page, Jonathan C Schisler","doi":"10.1016/j.cstres.2026.100166","DOIUrl":"10.1016/j.cstres.2026.100166","url":null,"abstract":"<p><p>Heat shock protein 70 (HSP70) and its E3 ligase co-chaperone CHIP (STUB1) form a critical quality-control complex that directs client proteins toward folding or degradation. Phosphorylation of HSP70 at a conserved threonine in the C-terminal tail influences the fate of clients during cellular stress, yet the structural basis for this regulation remains unclear. Here, we present crystal structures of the CHIP tetratricopeptide repeat (TPR) domain bound to unphosphorylated and phosphorylated HSP70 C-terminal peptides at 1.6-1.9Å resolution. Phosphate occupancy at Thr636 (HSPA1A numbering) causes steric clashes and electrostatic repulsion within the TPR-binding groove, decreasing affinity by more than 10-fold, as shown by biolayer interferometry and fluorescence polarization. Molecular dynamics simulations confirm destabilization of key hydrogen bonds. A structure-guided G132N substitution in CHIP introduces new hydrogen bonds to the phosphate group, restoring affinity for phosphorylated peptides in isolated TPR domains without losing native ubiquitination activity. However, in full-length CHIP, interface modifications do not restore phosphorylation-impaired stable binding but yield only partial recovery of transient interactions in cells, indicating additional context-dependent constraints on HSP70-CHIP regulation. These findings reveal the atomic mechanism by which phosphorylation impairs HSP70-CHIP interaction during stress and demonstrate that targeted interface engineering can compensate for post-translational changes in isolated domains. Overall, the results explain how cells switch chaperone-mediated triage pathways and offer a framework for understanding how proteostasis becomes dysregulated in neurodegenerative diseases and cancer.</p>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":" ","pages":"100166"},"PeriodicalIF":3.2,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06DOI: 10.1016/j.cstres.2026.100165
Xiaosheng Jiang, Brian S J Blagg
Heat shock protein 90 (Hsp90) is a highly conserved molecular chaperone that regulates the maturation of various client proteins. Most therapeutic studies have focused on N-terminal Hsp90 inhibitors, but these are limited by dose-escalating toxicities that are caused by induction of the heat shock response. Leonard Neckers' discovery of novobiocin as a Hsp90 C-terminal inhibitor revealed an alternative mode to Hsp90 inhibition and established the C-terminal domain (CTD) as a therapeutic target. This review highlights recent advances in Hsp90 CTD inhibition and summarizes the evolution of novobiocin-based C-terminal inhibitors. Structure-activity relationship studies are discussed, demonstrating how medicinal chemistry optimization has produced CTD modulators with selective anti-proliferative or neuroprotective activities.
{"title":"The Evolution of Hsp90 C-terminal Inhibitors: From Novobiocin to Potential Clinical Candidates.","authors":"Xiaosheng Jiang, Brian S J Blagg","doi":"10.1016/j.cstres.2026.100165","DOIUrl":"https://doi.org/10.1016/j.cstres.2026.100165","url":null,"abstract":"<p><p>Heat shock protein 90 (Hsp90) is a highly conserved molecular chaperone that regulates the maturation of various client proteins. Most therapeutic studies have focused on N-terminal Hsp90 inhibitors, but these are limited by dose-escalating toxicities that are caused by induction of the heat shock response. Leonard Neckers' discovery of novobiocin as a Hsp90 C-terminal inhibitor revealed an alternative mode to Hsp90 inhibition and established the C-terminal domain (CTD) as a therapeutic target. This review highlights recent advances in Hsp90 CTD inhibition and summarizes the evolution of novobiocin-based C-terminal inhibitors. Structure-activity relationship studies are discussed, demonstrating how medicinal chemistry optimization has produced CTD modulators with selective anti-proliferative or neuroprotective activities.</p>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":" ","pages":"100165"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147376138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-05DOI: 10.1016/j.cstres.2026.100164
Erick I Rios, Jill L Johnson
Hsp90 is an abundant and essential molecular chaperone that is required for the folding and/or activity of up to 15%-20% of all yeast proteins. Hsp90 and its cochaperone Cdc37 are of interest due to their cooperative role in chaperoning oncogenic protein kinases. We previously grouped mutants in Saccharomyces cerevisiae Hsp90 into different categories based on the step of the adenosine triphosphate-dependent Hsp90 folding cycle that is disrupted. Here we used a quantitative proteomic approach to compare the impact of two different mutations that target the initial step of loading clients onto Hsp90, one in Hsp90 and one in Cdc37. We also included two Hsp90 mutants that target other steps in the folding pathway. We tested the effects at either 25°C or after a 1-h heat shock at 37°C. As expected, the Cdc37 mutant and the Hsp90 mutant that affects the loading step had similar effects, particularly on protein kinases, demonstrating the potential for using proteomics for testing the impact of alteration of the folding pathway. We also identified non-kinase proteins that may use a similar Cdc37-mediated pathway. Surprisingly, protein kinases were a small subset of the proteins impacted by Cdc37 alteration, challenging the notion that Cdc37 is a kinase-specific cochaperone. We also identified proteins that were most strongly affected by Hsc82 mutants that impact steps other than the loading step. Further analysis of how Hsp90 and cochaperones interact with these additional proteins may provide novel insights into alternative methods of client loading or other poorly understood steps in the folding cycle.
{"title":"Comparative analysis of the impact of Heat shock protein 90 kDa or Cdc37 mutation on the yeast proteome.","authors":"Erick I Rios, Jill L Johnson","doi":"10.1016/j.cstres.2026.100164","DOIUrl":"10.1016/j.cstres.2026.100164","url":null,"abstract":"<p><p>Hsp90 is an abundant and essential molecular chaperone that is required for the folding and/or activity of up to 15%-20% of all yeast proteins. Hsp90 and its cochaperone Cdc37 are of interest due to their cooperative role in chaperoning oncogenic protein kinases. We previously grouped mutants in Saccharomyces cerevisiae Hsp90 into different categories based on the step of the adenosine triphosphate-dependent Hsp90 folding cycle that is disrupted. Here we used a quantitative proteomic approach to compare the impact of two different mutations that target the initial step of loading clients onto Hsp90, one in Hsp90 and one in Cdc37. We also included two Hsp90 mutants that target other steps in the folding pathway. We tested the effects at either 25°C or after a 1-h heat shock at 37°C. As expected, the Cdc37 mutant and the Hsp90 mutant that affects the loading step had similar effects, particularly on protein kinases, demonstrating the potential for using proteomics for testing the impact of alteration of the folding pathway. We also identified non-kinase proteins that may use a similar Cdc37-mediated pathway. Surprisingly, protein kinases were a small subset of the proteins impacted by Cdc37 alteration, challenging the notion that Cdc37 is a kinase-specific cochaperone. We also identified proteins that were most strongly affected by Hsc82 mutants that impact steps other than the loading step. Further analysis of how Hsp90 and cochaperones interact with these additional proteins may provide novel insights into alternative methods of client loading or other poorly understood steps in the folding cycle.</p>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":" ","pages":"100164"},"PeriodicalIF":3.2,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147372192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-10DOI: 10.1016/j.cstres.2026.100150
Matthew F. Tibi , Yoan M. Argote , Alyssa C. Walker , Swapnil Pandey , Cristian Puente , Garrett L. Ellward , Anan Safwat , Diego E. Rincon-Limas , Daniel M. Czyż
Neurodegenerative protein conformational diseases (PCDs) are progressive, currently incurable disorders driven by toxic protein aggregation that leads to neuronal death. Emerging evidence supports a microbial role in PCDs, including the most prevalent: Alzheimer’s and Parkinson’s disease. While metagenomic studies consistently associate gut dysbiosis with these disorders, the mechanisms by which microbes influence host proteostasis remain poorly understood. In particular, considerable attention has been given to proteotoxic bacteria, whereas the mechanisms by which commensal microbes confer proteoprotection have received comparatively little attention. We previously employed Caenorhabditis elegans models to characterize the role of over 220 bacterial isolates from the Human Microbiome Project on host proteostasis. Strikingly, members of the Prevotella genus exhibited proteoprotective effects. Most notably, transient exposure to Prevotella corporis uniquely induced Hsp70, a critical molecular chaperone that maintains proteostasis, and significantly reduced aggregation of polyglutamine (polyQ), A42, and α-synuclein. In the present study, we expand on these findings, demonstrating that among 13 Prevotella species tested, P. corporis robustly activates the heat shock response (HSR) and confers conserved aggregate-suppressing activity in Drosophila melanogaster. We further demonstrate that transient exposure to P. corporis results in the activation of protective stress pathways and promotes disaggregation of existing intestinal polyQ aggregates in C. elegans, leading to a general enhancement of global proteostasis. This is supported by significantly improved survival and enhanced thermotolerance. Together, our findings reveal a beneficial niche for P. corporis in activating the HSR to enhance organismal proteostasis and support a microbe-mediated gut-proteostasis axis. This work underscores the therapeutic potential of targeting the gut microbiota for the management of PCDs, highlights the importance of species-level resolution in microbiome studies, and supports the emerging view of the intestine as a proteostasis-modulating organ.
{"title":"Modulation of host proteostasis by Prevotella corporis via induction of the heat shock response","authors":"Matthew F. Tibi , Yoan M. Argote , Alyssa C. Walker , Swapnil Pandey , Cristian Puente , Garrett L. Ellward , Anan Safwat , Diego E. Rincon-Limas , Daniel M. Czyż","doi":"10.1016/j.cstres.2026.100150","DOIUrl":"10.1016/j.cstres.2026.100150","url":null,"abstract":"<div><div>Neurodegenerative protein conformational diseases (PCDs) are progressive, currently incurable disorders driven by toxic protein aggregation that leads to neuronal death. Emerging evidence supports a microbial role in PCDs, including the most prevalent: Alzheimer’s and Parkinson’s disease. While metagenomic studies consistently associate gut dysbiosis with these disorders, the mechanisms by which microbes influence host proteostasis remain poorly understood. In particular, considerable attention has been given to proteotoxic bacteria, whereas the mechanisms by which commensal microbes confer proteoprotection have received comparatively little attention. We previously employed <em>Caenorhabditis elegans</em> models to characterize the role of over 220 bacterial isolates from the Human Microbiome Project on host proteostasis. Strikingly, members of the <em>Prevotella</em> genus exhibited proteoprotective effects. Most notably, transient exposure to <em>Prevotella corporis</em> uniquely induced Hsp70, a critical molecular chaperone that maintains proteostasis, and significantly reduced aggregation of polyglutamine (polyQ), A<span><math><mi>β</mi></math></span>42, and α-synuclein. In the present study, we expand on these findings, demonstrating that among 13 <em>Prevotella</em> species tested, <em>P. corporis</em> robustly activates the heat shock response (HSR) and confers conserved aggregate-suppressing activity in <em>Drosophila melanogaster</em>. We further demonstrate that transient exposure to <em>P. corporis</em> results in the activation of protective stress pathways and promotes disaggregation of existing intestinal polyQ aggregates in <em>C. elegans,</em> leading to a general enhancement of global proteostasis. This is supported by significantly improved survival and enhanced thermotolerance. Together, our findings reveal a beneficial niche for <em>P. corporis</em> in activating the HSR to enhance organismal proteostasis and support a microbe-mediated gut-proteostasis axis. This work underscores the therapeutic potential of targeting the gut microbiota for the management of PCDs, highlights the importance of species-level resolution in microbiome studies, and supports the emerging view of the intestine as a proteostasis-modulating organ.</div></div>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":"31 2","pages":"Article 100150"},"PeriodicalIF":3.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146178008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-25DOI: 10.1016/j.cstres.2026.100161
Yu-Chieh Liao , Jorming Goh
High mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP). During cellular stress, it leaves the nucleus and moves into the extracellular space, where it modulates the development of cardiovascular diseases (CVDs), a leading global cause of age-related mortality. While evidence indicates that HMGB1 is associated with both the progression and severity of CVDs, it also has a paradoxically beneficial role in mitigating tissue repair. Exercise training improves cardiovascular function and modulates systemic concentrations of HMGB1. Acute exercise induces the release of HMGB1 into systemic concentration, whereas long-term exercise training appears to reduce its systemic levels. This paradoxical response of HMGB1 to either short-term or chronic exercise, alongside its complex role in the pathogenesis of age-associated CVDs, makes it an intriguing subject for research. A potential explanation for this paradox may lie in HMGB1’s capacity in regulating stem cell recruitment and tissue regeneration. This review explores the intricate interactions between HMGB1, exercise and CVDs, and discusses its potential both as a therapeutic target and a novel biomarker for tracking inflammatory signaling during exercise.
{"title":"High mobility group box 1: DAMPening the danger molecule in cardiovascular disease with exercise","authors":"Yu-Chieh Liao , Jorming Goh","doi":"10.1016/j.cstres.2026.100161","DOIUrl":"10.1016/j.cstres.2026.100161","url":null,"abstract":"<div><div>High mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP). During cellular stress, it leaves the nucleus and moves into the extracellular space, where it modulates the development of cardiovascular diseases (CVDs), a leading global cause of age-related mortality. While evidence indicates that HMGB1 is associated with both the progression and severity of CVDs, it also has a paradoxically beneficial role in mitigating tissue repair. Exercise training improves cardiovascular function and modulates systemic concentrations of HMGB1. Acute exercise induces the release of HMGB1 into systemic concentration, whereas long-term exercise training appears to reduce its systemic levels. This paradoxical response of HMGB1 to either short-term or chronic exercise, alongside its complex role in the pathogenesis of age-associated CVDs, makes it an intriguing subject for research. A potential explanation for this paradox may lie in HMGB1’s capacity in regulating stem cell recruitment and tissue regeneration. This review explores the intricate interactions between HMGB1, exercise and CVDs, and discusses its potential both as a therapeutic target and a novel biomarker for tracking inflammatory signaling during exercise.</div></div>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":"31 2","pages":"Article 100161"},"PeriodicalIF":3.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147316631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-12DOI: 10.1016/j.cstres.2026.100153
Yu Hao , Guangchuan Deng , Bolei Li , Lei Cheng , Shengguo Wang , Zhenzhou Yang
Developing effective therapeutic strategies for head and neck squamous cell carcinoma (HNSCC) remains a considerable clinical challenge. Cetuximab, a first-line targeted therapy for HNSCC, exhibits limited efficacy. The aim of this study was to explore the potential of α-1,3-mannosyltransferase (ALG3) inhibition in augmenting the therapeutic efficacy of cetuximab. We first analyzed the Cancer Genome Atlas (TCGA) data and found that ALG3 was significantly overexpressed in HNSCC tissues, correlating with worse pathological features and lower overall and disease-specific survival. Functional studies using ALG3-knockdown cells and a subcutaneous tumor model demonstrated that ALG3 inhibition markedly suppressed HNSCC proliferation both in vitro and in vivo. Furthermore, combining ALG3 inhibition with cetuximab elicited potent anti-cancer effects in vitro and in vivo. Mechanistic investigations via quantitative polymerase chain reaction, western blotting, and transmission electron microscopy revealed that ALG3 knockdown induced endoplasmic reticulum (ER) stress in HNSCC cells through the Bip/IRE1α axis. Finally, blocking N‑linked glycosylation synergistically enhanced cetuximab-mediated growth inhibition of HNSCC cells. In conclusion, ALG3 is a promising target to enhance the therapeutic efficacy of cetuximab in HNSCC.
{"title":"Inhibition of α-1,3-mannosyltransferase sensitizes head and neck squamous cell carcinomas to cetuximab via endoplasmic reticulum stress","authors":"Yu Hao , Guangchuan Deng , Bolei Li , Lei Cheng , Shengguo Wang , Zhenzhou Yang","doi":"10.1016/j.cstres.2026.100153","DOIUrl":"10.1016/j.cstres.2026.100153","url":null,"abstract":"<div><div>Developing effective therapeutic strategies for head and neck squamous cell carcinoma (HNSCC) remains a considerable clinical challenge. Cetuximab, a first-line targeted therapy for HNSCC, exhibits limited efficacy. The aim of this study was to explore the potential of α-1,3-mannosyltransferase (ALG3) inhibition in augmenting the therapeutic efficacy of cetuximab. We first analyzed the Cancer Genome Atlas (TCGA) data and found that ALG3 was significantly overexpressed in HNSCC tissues, correlating with worse pathological features and lower overall and disease-specific survival. Functional studies using ALG3-knockdown cells and a subcutaneous tumor model demonstrated that ALG3 inhibition markedly suppressed HNSCC proliferation both <em>in vitro</em> and <em>in vivo</em>. Furthermore, combining ALG3 inhibition with cetuximab elicited potent anti-cancer effects <em>in vitro</em> and <em>in vivo</em>. Mechanistic investigations <em>via</em> quantitative polymerase chain reaction, western blotting, and transmission electron microscopy revealed that <em>ALG3</em> knockdown induced endoplasmic reticulum (ER) stress in HNSCC cells through the Bip/IRE1α axis. Finally, blocking N‑linked glycosylation synergistically enhanced cetuximab-mediated growth inhibition of HNSCC cells. In conclusion, ALG3 is a promising target to enhance the therapeutic efficacy of cetuximab in HNSCC.</div></div>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":"31 2","pages":"Article 100153"},"PeriodicalIF":3.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cells counteract proteotoxic conditions by launching transcriptional stress responses. While synthesis of heat shock proteins (HSPs) upon acute stress is well characterized, how distinct proteotoxic conditions reshape the transcriptome remains poorly understood. Here, we analyse polyA+ RNA expression under heat shock, HSP90 inhibition, and polyglutamine (polyQ) aggregation. We find fundamentally distinct transcriptional responses to proteotoxic stressors and a systemic deficiency of mice under chronic stress to launch acute responses. While heat shock and HSP90 inhibition induce chaperones, polyQ aggregation increases expression of RNAs linked to transcription repression, chromatin remodeling, and autophagy. Analysing wild-type and Huntington's Disease (HD) mice reveals tissue-specific transcriptional adaptations to polyQ, including repressed cell-type specific functions and altered energy metabolism. Despite profound reprogramming, remarkably few genes exhibit consistently increased (Acy3, Abhd1, Tmc3) or decreased (Fos) RNA levels across HD brain regions. These results emphasize cellular background in disease manifestation and support energy metabolism and detoxifying enzymes as therapeutic targets in late-stage HD. Moreover, the systemic deficiency of chronically stressed mice to launch responses challenges strategies that rely on induced transcription. Altogether, we characterize transcription signatures to proteotoxic stresses, identify key trans-activators driving proteotoxic stress responses, provide an interactive gene-by-gene viewer of global changes, and delineate tissue-specific transcription programs in HD mice.
{"title":"Transcriptional responses to proteotoxic stressors are profoundly diverse and tissue-specific","authors":"Adelina Rabenius, Intisar Salim, Hilmar Lindström, Anastasiya Pak, Serhat Aktay, Anniina Vihervaara","doi":"10.1016/j.cstres.2026.100146","DOIUrl":"10.1016/j.cstres.2026.100146","url":null,"abstract":"<div><div>Cells counteract proteotoxic conditions by launching transcriptional stress responses. While synthesis of heat shock proteins (HSPs) upon acute stress is well characterized, how distinct proteotoxic conditions reshape the transcriptome remains poorly understood. Here, we analyse polyA+ RNA expression under heat shock, HSP90 inhibition, and polyglutamine (polyQ) aggregation. We find fundamentally distinct transcriptional responses to proteotoxic stressors and a systemic deficiency of mice under chronic stress to launch acute responses. While heat shock and HSP90 inhibition induce chaperones, polyQ aggregation increases expression of RNAs linked to transcription repression, chromatin remodeling, and autophagy. Analysing wild-type and Huntington's Disease (HD) mice reveals tissue-specific transcriptional adaptations to polyQ, including repressed cell-type specific functions and altered energy metabolism. Despite profound reprogramming, remarkably few genes exhibit consistently increased (<em>Acy3</em>, <em>Abhd1</em>, <em>Tmc3</em>) or decreased (<em>Fos</em>) RNA levels across HD brain regions. These results emphasize cellular background in disease manifestation and support energy metabolism and detoxifying enzymes as therapeutic targets in late-stage HD. Moreover, the systemic deficiency of chronically stressed mice to launch responses challenges strategies that rely on induced transcription. Altogether, we characterize transcription signatures to proteotoxic stresses, identify key <em>trans</em>-activators driving proteotoxic stress responses, provide an interactive gene-by-gene viewer of global changes, and delineate tissue-specific transcription programs in HD mice.</div></div>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":"31 2","pages":"Article 100146"},"PeriodicalIF":3.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-02-13DOI: 10.1016/j.cstres.2026.100152
Yang Guo , Dongsheng Guo , Ran Xu , Wenjin Qiu , Chenghao Peng
Purpose
Leucine-rich repeats and immunoglobulin-like domains 3 (LRIG3) functions as a tumor suppressor in glioma. Although our previous study demonstrated that LRIG3 inhibited angiogenesis via the PI3K/AKT/VEGFA pathway under normoxia, its impact on glioma vascularization under hypoxia remains elusive. Vasculogenic mimicry (VM), an alternative form of neovascularization, plays a pivotal role in glioma progression, particularly within hypoxic tumor microenvironments. This study aimed to investigate the effects of LRIG3 on hypoxia-induced VM in glioma and to elucidate the underlying molecular mechanisms.
Methods
The effects of LRIG3 on VM were evaluated in vitro using tube formation and 3D spheroid invasion assays. Histological analysis of intracranial xenografts and glioblastoma specimens was performed to assess LRIG3's impact on glioma vascularization in vivo. The underlying mechanisms were investigated using western blot, quantitative real-time PCR (qRT-PCR), and ubiquitination assays.
Results
LRIG3 expression was inversely correlated with VM density in the central hypoxic regions of both xenografts and glioblastoma specimens. Under hypoxia, LRIG3 overexpression inhibited the invasion and tube formation capacities of glioma cells, whereas its knockdown promoted these activities. Mechanistically, LRIG3 suppressed VM phenotypes by downregulating Snail2 at the post-translational level, rather than affecting VEGFA. LRIG3 promoted the ubiquitination of Snail2, leading to its proteasomal degradation and destabilization under hypoxia.
Conclusions
LRIG3 inhibits hypoxia-induced VM in glioma by facilitating the proteasomal degradation of Snail2 via ubiquitination.
{"title":"Leucine-rich repeats and immunoglobulin-like domains 3 suppresses hypoxia-induced vasculogenic mimicry in glioma by promoting the ubiquitination and degradation of Snail2","authors":"Yang Guo , Dongsheng Guo , Ran Xu , Wenjin Qiu , Chenghao Peng","doi":"10.1016/j.cstres.2026.100152","DOIUrl":"10.1016/j.cstres.2026.100152","url":null,"abstract":"<div><h3>Purpose</h3><div>Leucine-rich repeats and immunoglobulin-like domains 3 (LRIG3) functions as a tumor suppressor in glioma. Although our previous study demonstrated that LRIG3 inhibited angiogenesis via the PI3K/AKT/VEGFA pathway under normoxia, its impact on glioma vascularization under hypoxia remains elusive. Vasculogenic mimicry (VM), an alternative form of neovascularization, plays a pivotal role in glioma progression, particularly within hypoxic tumor microenvironments. This study aimed to investigate the effects of LRIG3 on hypoxia-induced VM in glioma and to elucidate the underlying molecular mechanisms.</div></div><div><h3>Methods</h3><div>The effects of LRIG3 on VM were evaluated in vitro using tube formation and 3D spheroid invasion assays. Histological analysis of intracranial xenografts and glioblastoma specimens was performed to assess LRIG3's impact on glioma vascularization in vivo. The underlying mechanisms were investigated using western blot, quantitative real-time PCR (qRT-PCR), and ubiquitination assays.</div></div><div><h3>Results</h3><div>LRIG3 expression was inversely correlated with VM density in the central hypoxic regions of both xenografts and glioblastoma specimens. Under hypoxia, LRIG3 overexpression inhibited the invasion and tube formation capacities of glioma cells, whereas its knockdown promoted these activities. Mechanistically, LRIG3 suppressed VM phenotypes by downregulating Snail2 at the post-translational level, rather than affecting VEGFA. LRIG3 promoted the ubiquitination of Snail2, leading to its proteasomal degradation and destabilization under hypoxia.</div></div><div><h3>Conclusions</h3><div>LRIG3 inhibits hypoxia-induced VM in glioma by facilitating the proteasomal degradation of Snail2 via ubiquitination.</div></div>","PeriodicalId":9684,"journal":{"name":"Cell Stress & Chaperones","volume":"31 2","pages":"Article 100152"},"PeriodicalIF":3.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146200203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}